Likelihood of inadequate treatment: A novel approach to evaluating drug-resistance patterns

Infection Control and Hospital Epidemiology

Volumn 30, Issue 7, 2009, Pages 672-677

  Burgmann, Heinz ^a,b   Stoiser, Brigitte ^a,b   Heinz, Gottfried ^a   Schenk, Peter ^a   Apfalter, Petra ^c   Zedtwitz Liebenstein, Konstantin ^b   Frass, Michael ^a   Carmeli, Yehuda ^a,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Division of Infectious Diseases   (Austria)

^c Division of Intensive Care 13 H3 ^*  (Austria)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFPIROME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AUSTRIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CALCULATION; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONY FORMING UNIT; DRUG TREATMENT FAILURE; FEMALE; FIBEROPTIC BRONCHOSCOPY; GENERAL HOSPITAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INTENSIVE CARE UNIT; LIKELIHOOD OF INADEQUATE THERAPY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUSTRIA; BRONCHOALVEOLAR LAVAGE FLUID; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAM-POSITIVE COCCI; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TREATMENT OUTCOME;

EID: 67651083566     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/598245     Document Type: Article

References (23)

1. Baughmann RP. Diagnosis of ventilator-associated pneumonia. Curr Opin Crit Care 2003; 9:397-402.
2. Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia: analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984; 129:668-671.
3. Jimenez P, Torres A, Rodriguez-Roisin R, et al. Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med 1989; 17:882-885.
4. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274:639-644.
5. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996; 275:866-869.
6. Kollef MH, Sharpless L, Vlasnik J, Pasque C., Murphy D, Fraser VJ. The impact of nosocomial infections on patients outcomes following cardiac surgery. Chest 1997; 112:666-675.
7. Bueno-Cavanillas A, Delgado-Rodriguez M, Lopez-Luque A, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994; 22:55-60.
8. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: results from amulticenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia. Intensive Care Med 1993; 19:256-264.
9. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235.
10. Kollef MH. Ventilator associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965-1970.
11. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998; 157:1151-1158.
12. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996; 15:281-285.
13. Rello J, Rue M, Jubert P, et al. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997; 25:1862-1867.
14. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003; 31:2544-2551.
15. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613.
16. Alvarez-Lerma F; ICU-Acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996; 22:387-394.
17. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903.
18. Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27:355-362.
19. Kollef MH, Sherman G,Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critical ill patients. Chest 1999; 115:462-474.
20. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685.
21. Binkley S, Fishman NO, LaRosa LA, et al. Comparison of unit-specific and hospital-wide antibiograms: potential implications for selection of empirical antimicrobial therapy. Infect Control Hosp Epidemiol 2006; 27:682-687.
22. Green DL. Selection of an empiric antibiotic regimen for hospital-acquired pneumonia using a unit and culture-type specific antibiogram. J Intensive Care Med 2005; 20:296-301.
23. Podbielsku A, Hermann M, Kniehl E, Mauch H, eds. Infections of the lower respiratory tract. In: Mauch H, Lütticken R, Gatermann S. MIQ 7: quality standards for microbiological diagnostic techniques for infectious diseases. Munich, Germany: Urban & Fischer Verlag, 1999:16-51.